GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of NRXP
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

NRx Pharmaceuticals, Inc. stock price took a fall of -27.75% on Thursday
(Updated on Apr 18, 2024)

Sell candidate since Apr 15, 2024 Loss -38.37% PDF

The NRx Pharmaceuticals, Inc. stock price fell by -27.75% on the last day (Thursday, 18th Apr 2024) from $4.18 to $3.02. It has now fallen 6 days in a row. During the last trading day the stock fluctuated 8.00% from a day low at $3.00 to a day high of $3.24. The price has fallen in 7 of the last 10 days and is down by -41.92% for this period. Volume has increased on the last day by 672 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 763 thousand shares were bought and sold for approximately $2.30 million.

Given the current short-term trend, the stock is expected to rise 16.20% during the next 3 months and, with a 90% probability hold a price between $3.51 and $8.73 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

NRXP Signals & Forecast

There are few to no technical positive signals at the moment. The NRx Pharmaceuticals, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $4.65 and $5.11. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, March 06, 2024, and so far it has fallen -56.89%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for NRx Pharmaceuticals, Inc. stock

NRx Pharmaceuticals, Inc. finds support from accumulated volume at $2.94 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.240 between high and low, or 8.00%. For the last week, the stock has had daily average volatility of 10.82%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NRXP) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect NRx Pharmaceuticals, Inc. to open at $3.09, and during the day (based on 14 day Average True Range), to move between $2.34 and $3.70, which gives a possible trading interval of +/-$0.676 (+/-22.39%) up or down from last closing price. If NRx Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 44.78% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $3.05 (0.93%) than the support at $2.94 (2.65%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is NRx Pharmaceuticals, Inc. stock A Buy?

The NRx Pharmaceuticals, Inc. stock holds several negative signals and despite the positive trend, we believe NRx Pharmaceuticals, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.750 Sell Candidate Unchanged

Predicted Opening Price for NRx Pharmaceuticals, Inc. of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$3.09 ( 2.21%) $3.02

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for NRXP

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.33 10.15 %
R2 3.23 7.12 %
R1 3.18 5.24 %
Current price: 3.02
Support S1 2.99 -0.83 %
S2 2.94 -2.70 %
S3 2.85 -5.74 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.70 22.52 %
R2 3.59 18.87 %
R1 3.05 0.93 %
Current price 3.02
Support S1 2.94 -2.65%
S2 0 .
S3 0 .

FAQ

What is the symbol for NRx Pharmaceuticals, Inc. Stock and on which exchange is it traded?
The symbol for NRx Pharmaceuticals, Inc. is NRXP and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell NRx Pharmaceuticals, Inc. Stock?
The NRx Pharmaceuticals, Inc. stock holds several negative signals and despite the positive trend, we believe NRx Pharmaceuticals, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy NRx Pharmaceuticals, Inc. Stock?
NRx Pharmaceuticals, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy NRx Pharmaceuticals, Inc. Stock.

What's the current price of NRx Pharmaceuticals, Inc. Stock?
As of the end of day on the 2024-04-18, the price of an NRx Pharmaceuticals, Inc. (NRXP) share was $3.02.

What is the 52-week high and low for NRx Pharmaceuticals, Inc. Stock?
The 52-week high for NRx Pharmaceuticals, Inc. Stock is $12.00 and the 52-week low is $2.21.

What is the market capitalization of NRx Pharmaceuticals, Inc. Stock?
As of the 2024-04-18, the market capitalization of NRx Pharmaceuticals, Inc. is 28.901M.

When is the next earnings date for NRx Pharmaceuticals, Inc.?
The upcoming earnings date for NRx Pharmaceuticals, Inc. is May 21, 2024.
Click to get the best stock tips daily for free!

About NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals. NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the treatment of bipolar depression in patients with acute suicidal... NRXP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT